While GLP-1s such as tirzepatide, semaglutide, and dulaglutide are known to reduce cardiovascular and all-cause mortality in patients with type 2 diabetes, their effects in patients who also have OSA remain unclear
Vision Changes : Report any vision changes, particularly if you have pre-existing diabetic retinopathy
Clinically, qualifying for GLP-1 therapy typically requires meeting one of two conditions: a BMI of 30 kg/m or greater, or a BMI of 27 kg/m or greater combined with an obesity-related comorbidity such as type 2 diabetes or cardiovascular risk factors
Phentermine) Suppresses appetite and boosts energy Daily pill, no injections May be combined with other therapies Convenient, flexible option All plans include: Monthly medication & supplies Diet & nutrition guidance Ongoing access to your provider See Your Transformation in 3D with the Styku Body Scanner Experience the future of body measurement with our advanced Styku 3D Body Scanner
Circadian rhythm disruption causes a decrease in GLP-1 production.[ref] Blue light exposure at night from screens (phone, TV, tablet) or LED lightbulbs causes circadian rhythm disruption
